# Omega 3 Oil: Aging-Related Cognitive Decline

> **NCT05041088** · PHASE1 · UNKNOWN · sponsor: **Neurological Associates of West Los Angeles** · enrollment: 40 (estimated)

## Conditions studied

- Aging Related Cognitive Decline

## Interventions

- **DIETARY_SUPPLEMENT:** ProdromeNeuro Plasmalogen

## Key facts

- **NCT ID:** NCT05041088
- **Lead sponsor:** Neurological Associates of West Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-20
- **Primary completion:** 2023-09-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05041088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05041088, "Omega 3 Oil: Aging-Related Cognitive Decline". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05041088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*